US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Delivery Market Research Reports & Industry Analysis

RSS Feeds

Drug Delivery Industry Research & Market Reports

1  2    4    6  7  8  9  10  
North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
1/31/2013 | published by: GlobalData
... Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others” provides key market data on the North America Drug Delivery Devices market – United States and Canada. The report provides value (USD million) data ...  |  read more...
USD 3,500
Europe Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
1/31/2013 | published by: GlobalData
... Inhaler Devices, Infusion Systems, Central Venous Catheters and Others” provides key market data on the Europe Drug Delivery Devices market – United Kingdom, Germany, France, Italy and Spain. The report provides value (USD million) data ...  |  read more...
USD 3,500
South Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
1/31/2013 | published by: GlobalData
... Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others” provides key market data on the South Africa Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) ...  |  read more...
USD 2,500
The 2013-2018 Outlook for Intranasal Drug Delivery Applications in Greater China
5/19/2013 | published by: Icon Group International, Inc.
... (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. ...  |  read more...
USD 495
The 2013-2018 World Outlook for Pulmonary Drug Delivery Technologies
7/15/2013 | published by: Icon Group International, Inc.
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow ...  |  read more...
USD 795
The 2013-2018 World Outlook for Intranasal Drug Delivery Applications
7/15/2013 | published by: Icon Group International, Inc.
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow ...  |  read more...
USD 795
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017
6/24/2013 | published by: MarketsandMarkets
... ocular, nasal, topical, implantable, and transmucosal drug delivery. Over the years, drug delivery technologies have grown phenomenally from plain drug reformulation and release technologies, to innovative platforms that hold a huge potential for the effective ...  |  read more...
USD 4,650
The 2013-2018 Outlook for Pulmonary Drug Delivery Systems in the United States
1/9/2013 | published by: Icon Group International, Inc.
... are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative benchmarks allow ...  |  read more...
USD 495
The 2013-2018 World Outlook for Drug Delivery Systems
1/7/2013 | published by: Icon Group International, Inc.
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the ...  |  read more...
USD 795
United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery
11/2/2012 | published by: Frost & Sullivan
... home. This is important for biotechnology products used in this area as companies seek to design new products and evaluate new opportunities for targeted therapies and other cancer treatments. This research examines the awareness and ...  |  read more...
USD 10,000
Needle-Free Drug Injection Systems and Safety Syringes: The Market for Alternatives to Traditional Needle-Based Delivery
2/1/2006 | published by: Kalorama Information
... administration, the traditional injection is still the dominant paradigm. However, the staggering costs and intransigent safety problems associated with sharps, along with consumer demand and the move to alternate-site care, are pushing for alternatives to ...  |  read more...
USD 2,200
Drug Delivery Markets, Vol III: Pulmonary Delivery Systems
3/1/2007 | published by: Kalorama Information
... delivery drugs into the blood circulation has been slowly transforming into reality. The pulmonary drug delivery market reached $25.5 billion in 2006 and is expected to experience high steady growth in the next five years. ...  |  read more...
USD 2,495
Pharmaceutical Excipients for Oral Formulations, 2nd. Edition
2/1/2008 | published by: Kalorama Information
... pharmaceuticals, aid the innovations in the drug development and help improve patent life as well. Excipients make the products more functional at a lower cost, a benefit much desired by the pharmaceutical industry that is ...  |  read more...
USD 995
The World Anesthesia Drug Market
4/1/2010 | published by: Kalorama Information
... development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product. Forecasted figures were generated using a combination of projected surgical procedures, patent and exclusivity expirations, pricing ...  |  read more...
USD 3,995
World Market for Respiratory Equipment and Disposables, 3rd. Edition
8/1/2008 | published by: Kalorama Information
... technological trends and society’s acceptance of people with disabilities. Kalorama's World Market for Respiratory Equipment and Disposables represents the third time that Kalorama Information has tackled this important device market. This report analyzes the worldwide ...  |  read more...
USD 2,995
Vaccines 2011-15: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
7/1/2011 | published by: Kalorama Information
... to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions. Kalorama Information has been closely following vaccine markets and has instituted a yearly market research ...  |  read more...
USD 1,500
Alternative Drug Delivery Systems
9/1/1995 | published by: Kalorama Information
... The systems featured are those that deliver therapeutic doses to selective targets, with fewer side effects, in ways that instigate greater compliance with the prescription routine while also improving patients' quality of life. The market ...  |  read more...
USD 1,625
The Market For Diabetes Drugs, Devices, And Disease Management
5/1/1996 | published by: Kalorama Information
... 2000. Examines newly approved drug therapies such as Bristol-Myers Squibb's Glucophage (metformin), home monitoring, and disease management programs. Describes pharmaceutical therapies in development for the treatment of diabetes or the reduction of complications--and their development ...  |  read more...
USD 1,625
Drug Delivery Series: The Market for Pulmonary Drug Delivery Systems: Volume 3
11/1/2001 | published by: Kalorama Information
... Drug Delivery Systems: Volume 3 Volume 3 of the Drug Delivery Series will address pulmonary drug delivery systems, including inhalation and intranasal. These systems have several advantages in terms of cost and ease of use.  |  read more...
USD 1,995
Drug Delivery Series: The Market for Transdermal and Transmucosal Drug Delivery Systems: Volume 4
1/1/2002 | published by: Kalorama Information
... transdermal and transmucosal drug delivery systems. Both of these systems continue to be of high interest for the delivery of proteins and peptides due to high permeability of mucosal tissue and adaptability of dermal application.  |  read more...
USD 1,995
Drug-Eluting Stents: Markets and Technologies
4/1/2003 | published by: Kalorama Information
... PTCA patients due to either thrombosis or abnormal tissue growth. As a result, restenosis constitutes the major limitation to the effectiveness of PTCA. To improve on this condition, medical science created stents in an attempt ...  |  read more...
USD 1,875
Advanced Drug Delivery: Technologies, Applications, and Markets
7/1/2003 | published by: Kalorama Information
... earlier stages. In Kalorama’s 2001-2002 Drug Delivery series, we focused on the markets by route of administration—oral, injectable, implantable, pulmonary, transdermal etc. In this all new study on advanced drug delivery, however, we focused on ...  |  read more...
USD 2,625
Drug Delivery Technology and Applications: A summary of Kalorama's market research, 2001-2003
11/7/2003 | published by: Kalorama Information
... of administration: Volume I: Oral Drug Delivery Volume II: Injectable and Implantable Drug Delivery Volume III: Pulmonary Drug Delivery Volume IV: Transdermal and Transmucousal Drug Delivery Volume V: Advanced Drug Delivery This series segmented the ...  |  read more...
USD 746
Anesthesia Drugs: Worldwide Markets
7/1/2007 | published by: Kalorama Information
... are correlated to prevalence and incidence in disease, and the resulting increase in procedure volumes. But as this market continues to grow, increased competition is steadily escalating in the United States and Europe, which is ...  |  read more...
USD 2,500
The World Market for Transdermal Drug Delivery
9/13/2012 | published by: Kalorama Information
... out, including sex hormones and pain management, due to the successful combination of the individual drug molecules and available product technologies. The potential benefits that may be achieved using transdermal delivery include continuous, controlled release ...  |  read more...
USD 995
1  2    4    6  7  8  9  10